New study analyses the use of AI software in imaging and detecting heart diseases. Credit: Communicator via Flickr.

Bay Labs has partnered with NorthWestern Medicine to assess the artificial intelligence (AI) based EchoGPS cardiac ultrasound guidance software suite for the detection of heart disease through cardiovascular imaging.

The ‘Seeing the Heart with AI Powered Echo’ (SHAPE) study has started enrolling patients. It will recruit a total of 1,200 participants across Northwestern Medicine sites.

Related Company Profiles

View all

EchoGPS is investigational software in an ultrasound system and leverages AI to help capture echocardiograms by providing real-time guidance to gain cardiac views.

The software suite also includes EchoMD, which has been designed to enable automated review of acquired images.

SHAPE study’s primary objective is to determine whether the EchoGPS software can be used by certified medical assistants (CMAs) without any previous experience to capture quality echocardiograms.

“The EchoGPS and EchoMD product suite has the potential to transform how cardiovascular care can be delivered in healthcare systems.”

The study will further evaluate if the echocardiogram images can be examined by cardiologists using EchoMD software to detect certain types of heart disease in patients aged 65 years and above, during routine physical examinations in a primary care setting.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Bay Labs co-founder and CEO Charles Cadieu said: “The EchoGPS and EchoMD product suite has the potential to transform how cardiovascular care can be delivered in healthcare systems.

“Incorporating our AI software with deep-learning technology into clinical practice could allow non-specialist medical professionals to acquire images to support cardiologist interpretation and clinical decision-making and may lead to improved patient outcomes through earlier detection and monitoring.”

The study is part of an ongoing Bay Labs and Northwestern Medicine collaboration focused on devising new techniques for the use of AI in clinical cardiovascular care.

It is also in line with Northwestern Medicine’s initiative to leverage AI for the study and treatment of cardiovascular disease.